PARP1 and neoplasm: In addition, combinations of PARP inhibitors and PI3K/AKT inhibitors also improved the treatment efficacy, in which PI3K signaling promoted the DNA double-strand repair through interaction with HRR complexes and inhibition of PI3K enhanced the anti-tumor effect of PARP inhibitors (60).